General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region Forums'The Sheer Greed Is Obscene': Moderna Plans 4,000% Markup for Covid Vaccine
The Massachusetts-based pharmaceutical giant Moderna faced angry backlash on Tuesday following the CEO's announcement that the firm is considering pricing its Covid-19 vaccine somewhere between $100 and $130 per dose in the United States.
The upper end of that range, according to the People's Vaccine Alliance (PVA), would represent a 4,000% markup above the cost of manufacturing the shot, which experts have pegged at roughly $2.85 per dose.
"The sheer greed is obscene," said PVA policy co-lead Julia Kosgei, who stressed that "billions of taxpayer dollars went into the development of mRNA vaccines."
"This vaccine isn't just Moderna's, it was developed in collaboration with a government agency based on decades of publicly-funded research," Kosgei said. "It is the people's vaccineand it should be available and affordable for everyone, everywhere."
Stephane Bancel, Moderna's billionaire CEO, defended the proposed price range in an interview on the sidelines of the J.P. Morgan Healthcare Conference in San Francisco, tellingThe Wall Street Journal that he believes "this type of pricing is consistent with the value" of the vaccine, which was developed with the crucial help of government scientists.
In 2020, Moderna admitted that 100% of the funding for its vaccine development program came from the federal governmentwhich, despite its leverage, has refused to force the company to share its vaccine recipe with the world.
https://www.commondreams.org/news/moderna-vaccine-price-markup
Goodheart
(5,325 posts)Actually, I was a cost accountant by trade, and R&D is NEVER included in financial statements as a manufacturing cost. It's been a few years, but as I recall GAAP by the FASB requires that research and development costs in any enterprise have to be recognized as expense in the period spent, and not later allocated to any product that might come out of that research.
So, what I'm saying is that often these stories of obscene greed are oversimplified and don't acknowledge the true costs of develping a product.
we can do it
(12,189 posts)From OP- In 2020, Moderna admitted that 100% of the funding for its vaccine development program came from the federal governmentwhich, despite its leverage, has refused to force the company to share its vaccine recipe with the world.
BlueCheeseAgain
(1,654 posts)How did the funding and program work?
PatSeg
(47,495 posts)Moderna has received almost $1 billion in taxpayer grants to get its vaccine through clinical trials and is considering setting the highest price of all coronavirus vaccine candidates.
Moderna's contract with the Biomedical Advanced Research and Development Authority, which is part of Health and Human Services, includes a provision that requires Moderna to "clearly state ... the percentage of the total costs of the program" financed with federal vs. private dollars.
Moderna has not done this in any of its press releases tied to its coronavirus vaccine. Two consumer advocacy groups, Public Citizen and Knowledge Ecology International, are now pushing HHS to "enforce the provision in this contract and all other applicable contracts."
There is more at the link:
https://www.axios.com/2020/08/05/moderna-barda-coronavirus-funding-disclosure
BlueCheeseAgain
(1,654 posts)womanofthehills
(8,718 posts)Looks like Moderna & NIH scientists both contributed.
From NYT November 2021
WASHINGTON Moderna and the National Institutes of Health are in a bitter dispute over who deserves credit for inventing the central component of the companys powerful coronavirus vaccine, a conflict that has broad implications for the vaccines long-term distribution and billions of dollars in future profits.
The vaccine grew out of a four-year collaboration between Moderna and the N.I.H., the governments biomedical research agency a partnership that was widely hailed when the shot was found to be highly effective. A year ago this month, the government called it the N.I.H.-Moderna Covid-19 vaccine. https:/
The agency says three scientists at its Vaccine Research Center Dr. John R. Mascola, the centers director; Dr. Barney S. Graham, who recently retired; and Dr. Kizzmekia S. Corbett, who is now at Harvard worked with Moderna scientists to design the genetic sequence that prompts the vaccine to produce an immune response, and should be named on the principal patent application.
Moderna disagrees. In a July filing with the United States Patent and Trademark Office, the company said it had reached the good-faith determination that these individuals did not co-invent the component in question. Its application for the patent, which has not yet been issued, names several of its own employees as the sole inventors. https://www.nytimes.com/2021/11/09/us/moderna-vaccine-patent.html
ancianita
(36,064 posts)There's also legal wrangling over vaccine patents.
These and other rival drug patent owners are asking federal courts for a cut of the profits Moderna Inc. and Pfizer Inc. collected from their revolutionary shots. How these battles play out will set the tone for other patent holders feeling left out of the Covid innovation race and future health crises.
At least seven lawsuits have been launched against makers of the mRNA Covid-19 vaccine, Bloomberg Law data show....
https://news.bloomberglaw.com/health-law-and-business/covid-vaccine-windfall-profits-under-attack-by-patent-holders
we can do it
(12,189 posts)ancianita
(36,064 posts)we can do it
(12,189 posts)ancianita
(36,064 posts)Hermit-The-Prog
(33,349 posts)Autumn
(45,105 posts)ancianita
(36,064 posts)Autumn
(45,105 posts)ancianita
(36,064 posts)The problem with developing an mRNA vaccine was that RNA hadn't been atomically mapped, and so couldn't even be "seen" until Jennifer Douda mapped it and won a Nobel Prize in Chemistry for that. https://en.wikipedia.org/wiki/Jennifer_Doudna
Autumn
(45,105 posts)Celerity
(43,406 posts)the rapacious profit motive from most all aspects of its healthcare system anytime soon. You see the same thing with many discussions of the expansive scam known as Medicare Advantage.
Reflexive, pro-corporate defences of the systemic extraction and transfer of wealth from the broad base up to the top of the pyramid, all involving what most all other adavanced nations on the planet consider a fundamental human right.
Autumn
(45,105 posts)obamanut2012
(26,080 posts)federal government."
AllyCat
(16,189 posts)Magoo48
(4,712 posts)Our common welfare means nothing to anyone but the common people.
appalachiablue
(41,142 posts)dalton99a
(81,515 posts)'Nuf said
BlueCheeseAgain
(1,654 posts)I'd like to hear more about that. Were they the only company that received funding? Did a lot of companies receive funding to develop a vaccine, and only Pfizer and Moderna were successful? If so, what reward should they get?
womanofthehills
(8,718 posts)What they're saying: NIH said in a statement that its scientists created the "stabilized coronavirus spike proteins for the development of vaccines against coronaviruses, including SARS-CoV-2," and the government consequently has "sought patents to preserve the government's rights to these inventions."
https://www.axios.com/2020/06/25/moderna-nih-coronavirus-vaccine-ownership-agreements
BumRushDaShow
(129,069 posts)It means tax-payer funded through NIH grants - https://covid19.nih.gov/funding#
The annual appropriations for HHS usually includes billions for this type of research.
January 4, 2023
Contacts
Christa Wagner, Manager, Government Relations
chwagner@aamc.org
Katherine Cruz, Legislative Analyst
kcruz@aamc.org
For Media Inquiries
press@aamc.org
On Dec. 29, 2022, President Joe Biden signed the Consolidated Appropriations Act, 2023 (H.R. 2617) into law, which includes $1.7 trillion in fiscal year (FY) 2023 discretionary government funding for all 12 annual spending bills, as well as a number of other health care provisions.
(snip)
National Institutes of Health (NIH)
The omnibus provides a total of $47.5 billion for the NIH in FY 2023, an increase of $2.5 billion (5.6%) above the FY 2022 enacted level. The bill provides increases to the Clinical and Translational Science Awards and the Institutional Development Award programs. The accompanying joint explanatory statement includes requirements regarding the reporting of the use of animals in research, funding for regional biocontainment laboratories and the workforce to support biosafety level 3-plus research, and funding to increase the diversity of the research workforce.
(snip)
https://www.aamc.org/advocacy-policy/washington-highlights/biden-signs-fy-23-omnibus-increases-research-health-workforce
Home / NIH Strategic Response to COVID-19 Decades in the Making: mRNA COVID-19 Vaccines
Two U.S. Food and Drug Administration (FDA)approved mRNA vaccines for COVID-19 have saved millions of lives. These vaccines were developed with NIH support and research on a protein found on SARS-CoV-2, the virus that causes COVID-19. Clinical trials for the COVID-19 vaccines in people were established in what seemed like record time. But in reality, more than 50 years of public and private laboratory research laid the groundwork for the rapid development of these life-saving vaccines.
Studies of viruses, including other coronaviruses, human immunodeficiency virus (HIV), and respiratory syncytial virus (RSV); advances in general vaccine technology; and the breakthrough in using fatty, oil-like particles called lipid nanoparticles to deliver vaccines to cells were just some of the efforts that made the mRNA COVID-19 vaccines possible. For decades, NIH has supported the research that led to these vaccines and this timeline provides some of the best examples.
(snip)
https://covid19.nih.gov/nih-strategic-response-covid-19/decades-making-mrna-covid-19-vaccines
For Billion-Dollar COVID Vaccines, Basic Government-Funded Science Laid the Groundwork
Much of the pioneering work on mRNA vaccines was done with government money, though drugmakers could walk away with big profits
By Arthur Allen, Kaiser Health News on November 18, 2020
When he started researching a troublesome childhood infection nearly four decades ago, virologist Dr. Barney Graham, then at Vanderbilt University, had no inkling his federally funded work might be key to deliverance from a global pandemic. Yet nearly all the vaccines advancing toward possible FDA approval this fall or winter are based on a design developed by Graham and his colleagues, a concept that emerged from a scientific quest to understand a disastrous 1966 vaccine trial.
Basic research conducted by Graham and others at the National Institutes of Health (NIH), Defense Department and federally funded academic laboratories has been the essential ingredient in the rapid development of vaccines in response to COVID-19. The government has poured an additional $10.5 billion into vaccine companies since the pandemic began to accelerate the delivery of their products. The Moderna vaccine, whose remarkable effectiveness in a late-stage trial was announced Monday morning, emerged directly out of a partnership between Moderna and Grahams NIH laboratory.
Coronavirus vaccines are likely to be worth billions to the drug industry if they prove safe and effective. As many as 14 billion vaccines would be required to immunize everyone in the world against COVID-19. If, as many scientists anticipate, vaccine-produced immunity wanes, billions more doses could be sold as booster shots in years to come. And the technology and production laboratories seeded with the help of all this federal largesse could give rise to other profitable vaccines and drugs.
The vaccines made by Pfizer and Moderna, which are likely to be the first to win FDA approval, in particular rely heavily on two fundamental discoveries that emerged from federally funded research: the viral protein designed by Graham and his colleagues, and the concept of RNA modification, first developed by Drew Weissman and Katalin Karikó at the University of Pennsylvania. In fact, Modernas founders in 2010 named the company after this concept: Modified + RNA = Moderna, according to co-founder Robert Langer.
(snip)
https://www.scientificamerican.com/article/for-billion-dollar-covid-vaccines-basic-government-funded-science-laid-the-groundwork/
As a general practice, "vaccines" are considered "loss leaders" for pharma companies and the various health agencies have actually had to beg them to make them. COVID-19 turned that on its head
leftstreet
(36,108 posts)Freethinker65
(10,023 posts)As well as promotion when competing vaccines become more readily available.
How much are comparable vaccines against shingles, HPV, etc. marked up?
While I do agree the US taxpayer funded all, or much of, the R & D, not allowing any profit could lead to a decrease, or even a possible cease, in production.
inthewind21
(4,616 posts)Do these same costs not exist in other countries? The defense of this BS is EXACTLY why we are gouged over and over and over again by pharma in this country.
jimfields33
(15,818 posts)Id imagine it costs more for mass production. More then Iceland that has 376,000 people.
Tom Rinaldo
(22,913 posts)If the margin was too tight they could possibly justify doubling the price or whatever, but a 4,000% increase?? For the sake of argument lets assume that they were just breaking even, all things considered, under current pricing. Heck, assume that, out of the goodness of their heart, they lost a buck on every dose. Now suddenly they raise that price by tens of dollars...
The Covid vaccine is not exactly an orphan drug. Literally Billions of doses get sold. A 50 cent profit per dose roughly equates to a billion dollars in profit, a ten dollar profit per dose roughly equates to 20 billion dollars in profit.
BlueCheeseAgain
(1,654 posts)They aren't increasing the price 4000%. The proposed price is 4000% of the manufacturing cost. Right now the federal government is apparently paying $26 per shot.
Tom Rinaldo
(22,913 posts)And they are raising the price from $26 to between $100 and $120 a shot, and if they ultimately sell a billion doses at that price, they will pile up about 75 billion dollars profit off of a product that taxpayers paid most of the research costs on.
Freethinker65
(10,023 posts)COVID vaccines had been provided "free" to all Americans (Government paid for the entire program which means US taxpayers paid for it).
$100 does not seem unreasonable to me, especially now that fewer Americans will be getting the vaccine and Moderna will still be devoting production time and space to it (along with promotion, storage, distribution, etc.). Alternative vaccines will be available, so as a company they need to watch the market.
This is a far cry from the EpiPen and similar fiascos.
Torchlight
(3,341 posts)Simply frustration at a 4000% mark up. Between the two absurd extremes, there are a host of options.
Freethinker65
(10,023 posts)Bet it was lots more than the stated "production" price in this thread.
Torchlight
(3,341 posts)I'm rather certain it would be insightful.
BlueCheeseAgain
(1,654 posts)fescuerescue
(4,448 posts)If they don't want to do it for that, then there are LOTS AND LOTS of other companies that would jump at it.
Freethinker65
(10,023 posts)ProfessorGAC
(65,060 posts)...but it rarely exceeds direct manufacturing cost, even in the pharmaceutical industry. Given the amount of resources applied to cGMP it's higher than in most industries but not that much, as a great deal of it is already sunk cost. They may only need to onboard 2 or 3 more people, as the departmental infrastructure already exists.
So, maybe adding those general administrative costs, takes us to $5 operational cost.
Since the R&D did not involve Moderna money, tacking on a recoupment of that investment is bogus.
This is still an unjustified increase.
Hekate
(90,714 posts)Walleye
(31,028 posts)SunSeeker
(51,566 posts)I mean, why not charge $5,000 for $5 penicillin, since it's "value" is quite high when you have a life threatening infection? The only reason they don't is because they don't have a patent lock on penicillin.
Bayard
(22,083 posts)By including it in the final price of the drug. Other countries don't let them get away with that.
So, if the government paid for the R&D here, there is no excuse for that pricing.
Ilsa
(61,695 posts)She donated big bucks to the Vanderbilt medical research group that helped develop the vaccine.
FakeNoose
(32,641 posts)Not to mention all the money our government paid the pharmaceuticals in the last 2 years.
Blues Heron
(5,937 posts)These pricks will never stop pulling this until we get national healthcare for all.
2naSalit
(86,646 posts)Best remedy for this, period.
Johonny
(20,851 posts)BlueCheeseAgain
(1,654 posts)All the cost is in development. Saying a vaccine shot should only cost $2.85 based on that is misguided.
It's the same way for many other things. The cost of streaming a movie is virtually zero. The cost of printing a book is virtually zero. The cost of a software license is virtually zero. Should all those things be free?
BumRushDaShow
(129,069 posts)due to the product being an injectable biologic, it does have a higher cost for quality control due to a requirement for an aseptic environment, consistent concentration of active ingredient per vial, and the ultra-low freezer storage requirements for holding long term.
judesedit
(4,439 posts)OMGWTF
(3,957 posts)housecat
(3,121 posts)2naSalit
(86,646 posts)An Executive Order is appropriate here.
fescuerescue
(4,448 posts)They should be forced to provide it at cost.
kacekwl
(7,017 posts)for profit company to make money. Its the OBSCENE profit that is totally unnecessary. Do top executives of every company have to make hundreds of millions of dollars ? On top of perks, benefits etc.? I'm all for folks making a good living but come on especially when so many of them are on government welfare, errr,ah subsidies.
Turbineguy
(37,338 posts)I mean it's either "own the libs" or send money to poor Alex Jones or the NRA.
Maybe they can make it up with a discount on AR-15s.
onecaliberal
(32,862 posts)We are just fucked over at every turn. Every god damn turn.
tavernier
(12,392 posts)People can get the vaccine elsewhere for a reasonable price and very soon they will go bankrupt. Isnt that capitalism?
Freethinker65
(10,023 posts)They will have competition. They will need to not only quality control produce the product, but also, store, promote, and distribute it.
It was never $2.84/dose post manufacture.
It is currently in everyone's best interest that they continue to produce this product and not turn their production to something less life saving but potentially more lucrative.
Competition will control the price and profit.
inthewind21
(4,616 posts)"Competition will control the price and profit." Now that's funny.
Skittles
(153,166 posts)these days they're more likely to be colluding